Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aquestive Therapeutics Inc.

3.25
0.0000
Post-market: 3.19-0.0600-1.85%19:32 EDT
Volume:2.27M
Turnover:7.37M
Market Cap:322.82M
PE:-5.52
High:3.30
Open:3.25
Low:3.17
Close:3.25
Loading ...

Aquestive Therapeutics announces two presentations on Anaphylm

TIPRANKS
·
25 Jun

Aquestive Therapeutics Unveils Promising Data on Anaphylm™ Sublingual Film for Severe Allergic Reactions at CFAAR Summit

Reuters
·
25 Jun

Aquestive Therapeutics (AQST) Gets a Buy from Raymond James

TIPRANKS
·
17 Jun

Lake Street Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST)

TIPRANKS
·
16 Jun

Aquestive Therapeutics Announces FDA Acceptance of New Drug Application for Anaphylm™ with PDUFA Date Set for January 31, 2026

Reuters
·
16 Jun

Aquestive Therapeutics Inc - FDA Assigns Pdufa Target Action Date of Jan 31, 2026

THOMSON REUTERS
·
16 Jun

Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and Pdufa Date for Anaphylm™ for the Treatment of Severe Allergic Reactions

THOMSON REUTERS
·
16 Jun

Aquestive Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
12 Jun

Those who invested in Aquestive Therapeutics (NASDAQ:AQST) three years ago are up 128%

Simply Wall St.
·
26 May

Aquestive Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
15 May

Aquestive Therapeutics' Shares Fall to 52-Week Low on 1Q Results, Outlook Cut

Dow Jones
·
13 May

Aquestive Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Aquestive Therapeutics, Inc. Q1 Adjusted Ebitda USD -17.639 Million

THOMSON REUTERS
·
13 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
12 May

Aquestive Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
10 May

Aquestive Therapeutics to Participate in Citizens Life Sciences Conference

GlobeNewswire
·
05 May

Aquestive Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
02 May

Strength Seen in Recursion Pharmaceuticals (RXRX): Can Its 27.7% Jump Turn into More Strength?

Zacks
·
14 Apr

Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium

GlobeNewswire
·
09 Apr

Aquestive Therapeutics Announces Positive Topline Pk Results From Its Pediatric Study and Completes the Nda Submission for Anaphylm™ (Epinephrine) Sublingual Film

THOMSON REUTERS
·
01 Apr